D&D Pharmatech Balance Sheet Health
Financial Health criteria checks 3/6
D&D Pharmatech has a total shareholder equity of ₩55.2B and total debt of ₩1.5B, which brings its debt-to-equity ratio to 2.8%. Its total assets and total liabilities are ₩79.2B and ₩24.0B respectively.
Key information
2.8%
Debt to equity ratio
₩1.52b
Debt
Interest coverage ratio | n/a |
Cash | ₩15.64b |
Equity | ₩55.22b |
Total liabilities | ₩23.99b |
Total assets | ₩79.20b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: A347850's short term assets (₩19.6B) exceed its short term liabilities (₩7.5B).
Long Term Liabilities: A347850's short term assets (₩19.6B) exceed its long term liabilities (₩16.5B).
Debt to Equity History and Analysis
Debt Level: A347850 has more cash than its total debt.
Reducing Debt: A347850's debt to equity ratio has increased from 0% to 2.8% over the past 5 years.
Debt Coverage: A347850's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if A347850's interest payments on its debt are well covered by EBIT.